Adtalem Global Education (NYSE:CVSA) Stock Rating Lowered by Truist Financial

Adtalem Global Education (NYSE:CVSA) was downgraded by investment analysts at Truist Financial from a “buy” rating to a “hold” rating in a research report issued on Thursday, MarketBeat.com reports. They presently have a $140.00 price objective on the stock. Truist Financial’s price objective points to a potential upside of 4.03% from the company’s previous close.

Several other brokerages also recently commented on CVSA. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Wednesday, August 19th. Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $170.00 target price on shares of Adtalem Global Education in a research report on Monday, June 8th. One analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $155.00.

Adtalem Global Education Price Performance

CVSA stock opened at $134.58 on Thursday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.09 and a quick ratio of 1.09. Adtalem Global Education has a 52-week low of $86.97 and a 52-week high of $156.26. The company’s 50-day moving average price is $128.15. The company has a market capitalization of $4.58 billion, a PE ratio of 19.12, a price-to-earnings-growth ratio of 0.99 and a beta of 0.63.

Adtalem Global Education (NYSE:CVSA) last posted its quarterly earnings data on Thursday, August 6th. The company reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19. The business had revenue of $501.38 million for the quarter. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. Equities analysts expect that Adtalem Global Education will post 9 EPS for the current fiscal year.

Insider Transactions at Adtalem Global Education

In other Adtalem Global Education news, CFO Robert J. Phelan sold 2,186 shares of the firm’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $135.15, for a total value of $295,437.90. Following the completion of the sale, the chief financial officer owned 48,306 shares in the company, valued at approximately $6,528,555.90. This trade represents a 4.33% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Manjunath Gangadharan sold 1,802 shares of the firm’s stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $137.18, for a total value of $247,198.36. Following the completion of the sale, the chief accounting officer owned 5,083 shares of the company’s stock, valued at $697,285.94. This represents a 26.17% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 27,753 shares of company stock valued at $3,717,982 in the last ninety days. 2.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in Adtalem Global Education stock. Kendall Capital Management bought a new position in Adtalem Global Education Inc. (NYSE:CVSA) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is currently owned by institutional investors.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.